Issue 24, 1990
From the journal:

Journal of the Chemical Society, Chemical Communications

Structural characterisation of the new brain imaging agent, [99mTc][TcO(L)], H3L =N-4-oxopentan-2-ylidene-N′-pyrrol-2-ylmethylethane-1,2-diamine

Gillian F. Morgan,   Ulrich Abram,   Guy Evrard,   Francois Durant,   Marcel Deblaton,   Pierre Clemens,   Paul Van den Broeck  and  John R. Thornback  

Abstract

Characterisation of [TcO(L)], a novel technetium complex currently undergoing Phase II clinical trial evaluation for cerebral perfusion, is reported.

About
Cited by
Related
Download options Please wait...

Article information

DOI
https://doi.org/10.1039/C39900001772
Article type
Paper

J. Chem. Soc., Chem. Commun., 1990, 1772-1773

Permissions

Request permissions

Structural characterisation of the new brain imaging agent, [99mTc][TcO(L)], H3L =N-4-oxopentan-2-ylidene-N′-pyrrol-2-ylmethylethane-1,2-diamine

G. F. Morgan, U. Abram, G. Evrard, F. Durant, M. Deblaton, P. Clemens, P. Van den Broeck and J. R. Thornback, J. Chem. Soc., Chem. Commun., 1990, 1772 DOI: 10.1039/C39900001772

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements